ArticleJournal of health, population, and nutrition2026
Comparison of novel nutritional index (TCBI) and insulin resistance index (TyG-BMI) for assessing cardiovascular disease risk: a cohort study.
Article in Journal of health, population, and nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Association of a novel nutritional index, the triglyceride-cholesterol-body weight index (TCBI), with incident mild cognitive impairment: CHARLS 2011-2018.Frontiers in nutrition · 2026Article
- Association between the composite nutritional index TCBI and ISR.Frontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiovascular disease (CVD) is a leading cause of death and disability worldwide, particularly among middle-aged and elderly populations. And early risk assessment is essential for early intervention and effective prevention. This study aims to investigate and compare the associations of the triglyceride, total cholesterol and body weight index (TCBI), a novel nutritional index, and the widely researched insulin resistance index-triglyceride glucose-body mass index (TyG-BMI) with CVD risk.
methodsUsing data from the CHARLS (2011-2020), including 8,104 participants without CVD at baseline. The associations of TCBI and TyG-BMI with CVD risk were assessed using Cox proportional hazards models and restricted cubic spline (RCS) analysis. Additionally, receiver operating characteristic (ROC) analysis, subgroup analysis and sensitivity analyses were also conducted.
resultsAfter 9 years, 1,840 participants developed CVD. Each 1-unit increase in log-transformed TCBI (LgTCBI) was associated with a 59% higher risk of CVD (HR 1.59, 95%CI 1.31-1.92, p < 0.001), while a 10-unit increase in TyG-BMI corresponded to a 6% higher risk (HR 1.06, 95% CI 1.04-1.07, p < 0.001). RCS analysis revealed a nonlinear relationship for TCBI and a linear one for TyG-BMI. ROC analysis indicated limited independent predictive accuracy for both indices, with area under the curve (AUC) values ranging from 0.556 to 0.576. In short-term prediction (2-4 years), TCBI and TyG-BMI showed similar discriminatory ability, whereas TyG-BMI performed slightly better in long-term prediction (7-9 years). The subgroup analysis indicated that there was no interaction between the subgroups and the two indices (p for interaction > 0.05). Sensitivity analyses confirmed the robustness of the results.
conclusionsTCBI and TyG-BMI were significantly associated with an increased CVD risk. Both indices demonstrated limited discriminative ability as standalone predictive tools, but TCBI performed comparably to TyG-BMI in short-term risk assessment, TyG-BMI held a slight advantage in long-term prediction. These findings suggest that TCBI and TyG-BMI may serve as simple, complementary screening tools to help identify high-risk individuals warranting further comprehensive clinical evaluation, rather than as standalone primary screening instruments and their clinical applicability requires further validation in diverse cohorts.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.